The Recall Desk
ModerateFDA (Drugs)·D-0633-2026·Announced 2026-06-24

Rapidol triple antibiotic first aid ointment recalled over manufacturing deviations

Rapidol Triple Antibiotic First Aid Ointment, 2 oz tubes, is being recalled because of CGMP deviations observed during an FDA inspection. 84 tubes are affected.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II recall arising from inspection-observed manufacturing deviations with no product defect or consequence described, which fits the Moderate band.

Plain-English summary

Rapidol Triple Antibiotic First Aid Ointment, containing bacitracin zinc 400 units, neomycin sulfate 3.5 mg and polymyxin-B sulfate 5,000 units, net weight 2 oz (57 g) tubes, distributed by Pharmadel LLC of New Castle, Delaware and made in India, is being recalled. The action covers 84 tubes.

The stated reason is CGMP deviations and deficiencies observed during an FDA inspection. The FDA classified the action as Class II. The source does not describe a resulting clinical consequence.

The affected lot is 0004, within expiry. Distribution was USA nationwide.

Consumers who have the affected lot should stop using it and follow the instructions issued by the firm.

The recalled product

Product
Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc 400 units, Neomycin Sulfate 3.5 mg, Polymyxin-B Sulfate 5,000 units, net wt. 2oz (57g) tubes, Distributed by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 10096 77162 9.
Manufacturer
Dabur India Limited
Category
Drug — Topical antibiotic ointment
Hazard
Affected units
84

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot# 0004
  • within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 14 recalled by Dabur India Limited under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 14 products in this recall →

Related recalls

Same manufacturer · Dabur India Limited

See all →

Same hazard · cgmp deviation

See all →